XML 106 R89.htm IDEA: XBRL DOCUMENT v3.3.1.900
Pro Forma Information – Viro Acquisition (Details)-K - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Net sales $ 6,730 $ 7,642
Earnings (loss) from continuing operations attributable to the Company $ (41) $ 97
Diluted earnings per share from continuing operations $ (0.25) $ 0.58
As Reported    
Net sales $ 6,156 $ 6,784
Earnings (loss) from continuing operations attributable to the Company $ (70) $ 98
Diluted earnings per share from continuing operations $ (0.44) $ 0.59
Vitro F&B Adjustments    
Net sales $ 574 $ 858
Earnings (loss) from continuing operations attributable to the Company 75 70
Financing Adjustments    
Earnings (loss) from continuing operations attributable to the Company $ (46) $ (71)